JB Chemicals & Pharmaceuticals Ltd receives ANDA approval for Venlafaxine Hydrochloride Extended-Release Tablets from USFDA

JB Chemicals & Pharmaceuticals Ltd has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precision-controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and 225 mg, of Osmotica Pharmaceutical U.S. LLC.

As per IQVIA Health MAT Oct 2022 data, Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US.

Shares of JB Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 2017.15 as compared to the previous close of Rs. 2025.45. The total number of shares traded during the day was 2239 in over 401 trades.

The stock hit an intraday high of Rs. 2037.10 and intraday low of 2005.00. The net turnover during the day was Rs. 4526854.00.

Source : Equity Bulls

Keywords

JBChemicalsandPharmaceuticals INE572A01028 ANDAApproval USFDA Venlafaxine ExtendedReleaseTablets